Anaplastic Large Cell Lymphoma Not Yet Recruiting Phase 1 Trials for DB08870 (Brentuximab vedotin)

Also known as: Lymphomas, Anaplastic Large-Cell / Anaplastic large-cell lymphoma / Large cell (Ki-1+) lymphoma / Lymphoma, Large-Cell, Anaplastic / Anaplastic large cell lymphoma, CD30-positive

IndicationStatusPhase
DBCOND0028602 (Anaplastic Large Cell Lymphoma)Not Yet Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs